Glassman Wealth Services’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-107
| Closed | -$10.3K | – | 1591 |
|
|
2023
Q4 | $10.3K | Buy |
107
+10
| +10% | +$964 | ﹤0.01% | 874 |
|
|
2023
Q3 | $11.8K | Sell |
97
-1
| -1% | -$121 | ﹤0.01% | 809 |
|
|
2023
Q2 | $11.2K | Hold |
98
| – | – | ﹤0.01% | 781 |
|
|
2023
Q1 | $13.5K | Sell |
98
-1
| -1% | -$138 | ﹤0.01% | 728 |
|
|
2022
Q4 | $12.8K | Buy |
99
+1
| +1% | +$130 | ﹤0.01% | 766 |
|
|
2022
Q3 | $11K | Hold |
98
| – | – | ﹤0.01% | 775 |
|
|
2022
Q2 | $7K | Sell |
98
-59
| -38% | -$4.21K | ﹤0.01% | 924 |
|
|
2022
Q1 | $12K | Sell |
157
-35
| -18% | -$2.68K | ﹤0.01% | 786 |
|
|
2021
Q4 | $17K | Buy |
192
+21
| +12% | +$1.86K | ﹤0.01% | 662 |
|
|
2021
Q3 | $16K | Buy |
171
+80
| +88% | +$7.49K | ﹤0.01% | 646 |
|
|
2021
Q2 | $7K | Buy |
91
+84
| +1,200% | +$6.46K | ﹤0.01% | 845 |
|
|
2021
Q1 | $1K | Sell |
7
-88
| -93% | -$12.6K | ﹤0.01% | 1325 |
|
|
2020
Q4 | $16K | Buy |
95
+56
| +144% | +$9.43K | ﹤0.01% | 597 |
|
|
2020
Q3 | $5K | Buy |
39
+3
| +8% | +$385 | ﹤0.01% | 803 |
|
|
2020
Q2 | $6K | Buy |
36
+19
| +112% | +$3.17K | ﹤0.01% | 597 |
|
|
2020
Q1 | $2K | Buy |
17
+5
| +42% | +$588 | ﹤0.01% | 751 |
|
|
2019
Q4 | $2K | Hold |
12
| – | – | ﹤0.01% | 789 |
|
|
2019
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 916 |
|
|
2019
Q2 | $2K | Sell |
12
-1
| -8% | -$167 | ﹤0.01% | 749 |
|
|
2019
Q1 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 721 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | -$1K | – | 971 |
|
|
2018
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 739 |
|
|
2018
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 725 |
|
|
2018
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 912 |
|
|
2017
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 782 |
|